ArticleClinical drug investigation2025

Economic Evaluation of Penpulimab Plus Paclitaxel and Carboplatin Combination Therapy as First-Line Treatment for Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer in China.

Meng Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.